Accessing US markets – Nasdaq and FDA approval
37:41•2021-04-21
Jaksokuvaus
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan Baldwin and Phamaxis CEO Gary Phillips.
Uusimmat jaksot
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-06-22 • 37min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-06-01 • 1h 2min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-03-21 • 49min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2022-02-10 • 34min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-12-22 • 31min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-11-08 • 42min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-10-26 • 35min
Investing in Biotech from Horizon 3 Biotech
BioBullets: The Great Dispersion
2021-09-17 • 13min
Investing in Biotech from Horizon 3 Biotech
Investing in Biotech
2021-09-13 • 37min
Investing in Biotech from Horizon 3 Biotech
BioBullets: The Aduhelm FDA approval controversy
2021-08-13 • 10min